81 related articles for article (PubMed ID: 23292503)
1. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
[TBL] [Abstract][Full Text] [Related]
2. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin inhibits fibrosis of the palmar aponeurosis in Dupuytren's contracture in male patients.
Yamanaka Y; Tajima T; Tsujimura Y; Naito T; Mano Y; Tsukamoto M; Zenke Y; Sakai A
Bone Joint Res; 2023 Aug; 12(8):486-493. PubMed ID: 37536684
[TBL] [Abstract][Full Text] [Related]
5. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
[TBL] [Abstract][Full Text] [Related]
6. Dupuytren's contracture-associated SNPs increase SFRP4 expression in non-immune cells including fibroblasts to enhance inflammation development.
Kida H; Jiang JJ; Matsui Y; Takahashi I; Hasebe R; Kawamura D; Endo T; Shibayama H; Kondo M; Nishio Y; Nishida K; Matsuno Y; Oikawa T; Kubota SI; Hojyo S; Iwasaki N; Hashimoto S; Tanaka Y; Murakami M
Int Immunol; 2023 Jul; 35(7):303-312. PubMed ID: 36719100
[TBL] [Abstract][Full Text] [Related]
7. Deciphering Mesenchymal Drivers of Human Dupuytren's Disease at Single-Cell Level.
Dobie R; West CC; Henderson BEP; Wilson-Kanamori JR; Markose D; Kitto LJ; Portman JR; Beltran M; Sohrabi S; Akram AR; Ramachandran P; Yong LY; Davidson D; Henderson NC
J Invest Dermatol; 2022 Jan; 142(1):114-123.e8. PubMed ID: 34274346
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of Dupuytren's fibrosis via targeting of the STAT1 modulated IL-13Rα1 response.
Akbar M; Garcia-Melchor E; Chilaka S; Little KJ; Sood S; Reilly JH; Liew FY; McInnes IB; Millar NL
Sci Adv; 2020 Jul; 6(28):eaaz8272. PubMed ID: 32695877
[TBL] [Abstract][Full Text] [Related]
9. In vitro modeling of repetitive motion strain and manual medicine treatments: potential roles for pro- and anti-inflammatory cytokines.
Standley PR; Meltzer K
J Bodyw Mov Ther; 2008 Jul; 12(3):201-3. PubMed ID: 19083676
[TBL] [Abstract][Full Text] [Related]
10. Co-Expression Analysis of Airway Epithelial Transcriptome in Asthma Patients with Eosinophilic vs. Non-Eosinophilic Airway Infiltration.
Kozlik-Siwiec P; Buregwa-Czuma S; Zawlik I; Dziedzina S; Myszka A; Zuk-Kuwik J; Siwiec-Kozlik A; Zarychta J; Okon K; Zareba L; Soja J; Jakiela B; Kepski M; Bazan JG; Bazan-Socha S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835202
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the expression of chaperonin containing TCP1 subunits (CCTs) and their influence on prognosis in hepatocellular carcinoma.
Fu R; Jiang S; Guan Z; Li J; Zhang X; Chen H
Transl Cancer Res; 2020 Mar; 9(3):1867-1883. PubMed ID: 35117534
[TBL] [Abstract][Full Text] [Related]
12. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
13. Management of limited joint mobility in diabetic patients.
Abate M; Schiavone C; Salini V; Andia I
Diabetes Metab Syndr Obes; 2013; 6():197-207. PubMed ID: 23690694
[TBL] [Abstract][Full Text] [Related]
14. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
[TBL] [Abstract][Full Text] [Related]
15. Chaperonin containing T-complex polypeptide subunit eta (CCT-eta) is a specific regulator of fibroblast motility and contractility.
Satish L; Johnson S; Wang JH; Post JC; Ehrlich GD; Kathju S
PLoS One; 2010 Apr; 5(4):e10063. PubMed ID: 20442790
[TBL] [Abstract][Full Text] [Related]
16. Chaperonin containing T-complex polypeptide subunit eta is a potential marker of joint contracture: an experimental study in the rat.
He R; Wang Z; Lu Y; Huang J; Ren J; Wang K
Cell Stress Chaperones; 2015 Nov; 20(6):959-66. PubMed ID: 26220476
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
